NEMLUVIO

NEMOLIZUMAB-ILTO · Galderma Laboratories, L.P.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NEMLUVIO, covering 2024-08-12 to 2026-03-02. Get the full timeline:

Most recent: EMA Authorised: Nemluvio (nemolizumab) — Galderma International